Five-Year Study of Anticoagulants

Simson, G. : Intermittent Dicumarol therapy. Rocky Mountain M. J., 54: 723, 1957.

Bourgain, R. , Todd, M. , Symons, C. , Herzig, L. , AND Wright, I. A comparative study of Marcumar, Tromexan and Dicumarol. Schweiz. med. Wchnschr., 29: 820, 1954.

Bourgain, R. , Todd, M. , Herzig , L. , AND Wright, I. : Marcumar 3- (1-phenyl-propyl)-4-hydroxycoumarin. A new anticoagulant. Circulation, 10: 680, 1954.

Prior, I. : Anticoagulant studies with "Marcoumar," a new coumarin derivative . Brit. M. J., 2: 944, 1955.

Toohey, M. : Phenyl-propyl-hydroxycoumarin as an Anticoagulant. Brit. M. J., 1: 9, 1956.

Fourbairn, J. , AND Estes, J. : Clinical experience with 3-(1-phenyl-propyl)-4-hydroxycoumarin. Proc. Staff Meet., Mayo Clin., 32: 342, 1957.

Ensor, R. , AND Peters, H. : Experience with the anticoagulant, Marcumar. Ann. Int. Med. , 47: 731, 1957.

Priest, E. , AND Pauli, H. : Phenprocoumon (Marcumar). 1. An agent for short-term anticoagulant therapy . Am. J. Cardiol., 11: 61,1958.

Gold, H. , AND Lilley, G. : New anticoagulant for oral use 3-(1-phenyl-propyl)-4-hydroxycoumarin (Liquamar) . J. A. M. A., 170: 123, 1959.

Astrup, T. , AND Mullertz, S. : Standardized estimation of prothrombin activity and the accurate control of Dicumarol therapy. Schweiz. med. Wchnschr., 29: 815, 1954.

Quick, A. : The relation of coagulation of the blood to intravascular clotting . Schweiz. med. Wehnschr., 29: 783, 1954.